iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

IOL Chemicals and Pharma stock zooms 5% on commencement of commercial production of 'Paracetamol'

25 Apr 2022 , 12:42 PM

IOL Chemicals & Pharmaceuticals Ltd has informed that the Company has commenced the commercial production of ‘Paracetamol’ with installed capacity of 1800 MTPA along with backward integration of Para Amino Phenol (PAP) with effect from April 22, 2022.

The Company is manufacturing Paracetamol in its existing Unit No 4, which has been converted as multiproduct facility, with a cost of about Rs100 lakh whereas PAP is being manufactured in part of Unit No 9. The Company shall continue to use Unit 4 & Unit 9 for manufacturing other products as per market conditions.

Further, considering the present market scenario, the Company is in the process of enhancing the installed capacity for manufacturing the Paracetamol from 1800 MTPA to 3600 MTPA with a capex of about Rs25 crore, which is expected to be completed during the 3rd quarter of FY2023.

All the capex is being met through internal accruals only, said company in a regulatory filing.

The Paracetamol, also known as Acetaminophen, is an Active Pharma ingredient (API) that is used to treat fever and mild pain, whereas PAP is used as an intermediate to manufacture Paracetamol.

At around 12:44 PM, IOL Chemicals & Pharmaceuticals was trading at Rs478.65 per piece up by 5.15% on the BSE.

Related Tags

  • business update
  • commercial production
  • IOL Chemicals & Pharmaceuticals Ltd
  • IOL Chemicals & Pharmaceuticals Ltd shares
  • IOL Chemicals & Pharmaceuticals Ltd stocks
  • news
  • Paracetamol
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.